Please login to the form below

Crohn's Disease

This page shows the latest Crohn's Disease news and features for those working in and with pharma, biotech and healthcare.

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Hopes to aid growth. Takeda has new clinical data on a subcutaneous formulation of its Entyvio drug in Crohn’s disease, expanding the potential of the drug beyond ulcerative colitis. ... Top-line results from the VISIBLE 2 trial show the new

Latest news

Tiziana joins type 1 diabetes prevention field

Currently, Foralumab is in a phase 1 trial at the Harvard Medical School to study its effects on neurodegenerative disease through nasal delivery. ... Tiziana have also planned an upcoming phase 1 trial which will evaluate the use of foralumab's use in
Latecomer Lilly preps its IL-23 drug for Crohn’s disease

some of its rivals in Crohn’s disease. ... Crohn's disease.”.
European approval for Skyrizi, hot on the heels of US

The analysis showed that 56% of patients on risankizumab were symptom-free after a year’s treatment, compared to 30% of the Stelara group. ... The drug is already in trials for psoriatic arthritis, Crohn's disease and ulcerative colitis.
Gilead and Galapagos close in on filing for Xeljanz rival

In FINCH 1, selective JAK1 inhibitor filgotinib was compared to AbbVie’s $18bn-a-year TNF antibody Humira (adalimumab) or placebo – given on top of generic disease-modifying antirheumatic drug (DMARD) ... RA and the rest from other diseases such as
Celgene hopes for second time lucky for ozanimod FDA filing

The mistake was seen as a huge own goal by Celgene, and further undermined already shaky investor confidence in the company's leadership. ... Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, and is also being developed to treat

More from news
Approximately 20 fully matching, plus 144 partially matching documents found.

Latest Intelligence

Drug launches to watch in 2019

The first test of this will be Shire’s new blockbuster-in-waiting Takhzyro, which gained EMA approval in November, for the rare disease hereditary angioedema (HAE). ... Boehringer Ingelheim) for psoriatic arthritis, Crohn’s disease and other
Deal Watch October 2018

Collaboration for. development. $760m. Enterome/. Takeda. EB8018 for Crohn’s disease and other gastrointestinal. ... Roche has an existing agreement with Ionis for IONIS‐HTTRx, an antisense drug for Huntington’s Disease, and the new deal is to
Innovation in merger control and the impact on the pharmaceutical sector

Pipeline problems. The Commission’s novel approach has its roots in pharma mergers. ... Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s
Deal Watch January 2018

for local administration for the treatment of complex perianal fistulas in patients with Crohn’s disease. The companies were already partners having signed a $432m licensing deal in July 2016 for ... Option exercise (2 options). 640. TiGenix/Takeda.
The good, the bad and the ugly

Tecfidera (MS) and Spinraza (Spinal Muscular Atrophy) are expected to generate big sales, while Tysabril (MS and Crohn’s Disease) and Avonex (MS) are expected to see sales drop due to ... However, there is a movement towards greater research in this

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

TiGenix appoints Dr Marie Paule Richard

in phase III trials for complex perianal fistulas in Crohn's disease.
Ex J&J VP joins board of Immune

Immune will benefit from Durrant's knowledged of the iundstry gained during time in roles such as worldwide VP at Johnson &Johnson and VP, Pharmacia until its acquisition by Pfizer. ... Its lead product candidate is bertilimumab, which is in clinical
Former Novartis president joins Qu Biologics

His senior industry experience will support Qu Biologics' plans to advance the development of its investigational immunotherapies for treatments such as Crohn's disease. ... Bob Pelzer's wealth of leadership experience with Novartis and DuPont will be

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Cello Health Insight wins EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'

Cello Health Insight in partnership with Janssen Pharmaceuticals has won EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'. ... The winning entry focused on exploring the Crohn’s Disease and Ulcerative Colitis
The Real & The Honestly Fake

If the audience’s attention span has decreased, agencies and advertisers must grab what little attention there is. ... about how to deal with Duchenne, the depictions of dragons to represent the struggles of suffering with Crohn’s disease, the
emotive adds to medical team with new Scientific Lead and Associate Medical Writer

Kate is experienced in a wide range of therapy areas, including immunology, specifically Crohn’s disease, ulcerative colitis and psoriatic arthritis, in ophthalmology, including retinal diseases, glaucoma and dry eye disease, ... in rare
THE OTHER SIDE OF… CROHN’S DISEASE

Meet Irene. Like millions of others worldwide (and an estimated 115, 000 in the UK), Irene suffers from Crohn’s disease, an autoimmune disorder that causes inflammation in the gut and ... So she turns elsewhere for information. She speaks to other
Creativity in a complex landscape: a pharma perspective

For example, when developing messaging, it’s important to know what restrictions and barriers might come into play for different countries. ... An example of what I would consider an outstanding creative campaign is the ‘Rewrite Their Stories’

More from PMHub
Approximately 5 fully matching, plus 9 partially matching documents found.

Featured jobs

Account Director – UK Office: Excellent salary and benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Events Executive: DOE

Account Manager – Healthcare advertising: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...